Related Articles
EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β‑catenin/E‑cadherin pathway
Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells
EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients
EBP50 gene transfection promotes 5-fluorouracil-induced apoptosis in gastric cancer cells through Bax- and Bcl-2-triggered mitochondrial pathways
Clinical significance of EBP50 overexpression assessed by quantum dot analysis in gastric cancer